Curis Signs Securities Purchase Agreement for Up to $80.8M
Curis announced that it has entered into a securities purchase agreement with new and existing healthcare-focused, high-quality institutional investors and certain insiders of the company for a private placement for gross proceeds of up to $80.8M to the company, including initial gross proceeds to the company of approximately $20.2M, in each case before placement agent fees and offering expenses. The PIPE financing is expected to close on or about January 8, 2026, subject to the satisfaction of customary closing conditions. Laidlaw & Company is acting as sole placement agent for the PIPE financing.
